Orthopedics > OCOSH Classification > Complications > Venous Thromboembolism > Dabigatran A New Oral Agent for Prevention of Venous Thromboembolism COA

< Previous | Next >

Dabigatran A New Oral Agent for Prevention of Venous Thromboembolism COA

Visit Resource Review It Rate It Bookmark It

Location: http://www.coa-aco.org/coa-bulletin/issue-83/dabigatran-a-new-oral-agent-for-prevention-of-venous-th ...

Description: Recently, the first oral direct thrombin inhibitor became available for the prevention of VTE in patients undergoing elective total hip or knee replacement surgery. Dabigatran etexilate (PradaxTM) is a prodrug of dabigatran, a highly specific inhibitor of both clot-bound and free thrombin that can be used in both the hospital and outpatient setting.
Fathi Abuzgaya, M.D., FRCSC COA Bulletin Issue 83 2008

Type: Reference Material
Author/Contact: Fathi Abuzgaya, M.D., FRCSC
Institution: COA
Primary Subject/Category:

Language: English

Submitted by: admin
Hits: 920
Added: Wed Jul 01 2009